BGNE - Beigene, Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BGNE (1651308)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
46 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-11-18
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$194.34-25,000122,317-17%-$4,858,616
D
2019-11-18
BGNEHuang JaneCMO, HematologyS - Sale+OE$194.49-1,500291,667-1%-$291,740
M
2019-11-14
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$194.63-13,0007,685,0020%-$2,530,198
2019-11-15
BGNEWu XiaobinPres, GM ChinaS - Sale$202.05-1,0001,483,9560%-$202,050
D
2019-11-04
BGNEHuang JaneCMO, HematologyS - Sale+OE$190.46-32,900291,667-10%-$6,266,007
DM
2019-11-04
BGNEChen Timothy Yung-ChengDirS - Sale+OE$189.86-8,0000-100%-$1,518,845
M
2019-11-01
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$180.00-2,00012,758,0000%-$360,000
2019-11-01
BGNEWu XiaobinPres, GM ChinaS - Sale$180.00-1,0001,496,9560%-$180,000
M
2019-09-03
BGNEHuang JaneCMO, HematologyS - Sale$144.03-2,944291,667-1%-$424,030
D
2019-08-23
BGNEChen Timothy Yung-ChengDirS - Sale+OE$144.96-8,6140-100%-$1,248,680
D
2019-08-12
BGNEHuang JaneCMO, HematologyS - Sale+OE$134.74-2,500328,873-1%-$336,855
D
2019-07-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$134.54-10,130328,873-3%-$1,362,896
2019-07-08
BGNEOyler JohnCEOS - Sale$126.87-3,10664,505,6850%-$394,055
2019-06-27
BGNEHuang JaneCMO, HematologyS - Sale$124.52-430328,8730%-$53,542
2019-06-27
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale$9.47-5,876122,317-5%-$55,653
2019-07-01
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$126.46-4,84712,784,0000%-$612,937
DM
2019-05-20
BGNEHuang JaneCMO, HematologyS - Sale+OE$130.07-2,500271,621-1%-$325,168
D
2019-05-21
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$130.21-23,20052,338-31%-$3,020,860
2019-05-13
BGNEGlazer Donald W.DirS - Sale$125.11-15,0273,949,6780%-$1,880,028
D
2019-05-06
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$130.01-1,80052,338-3%-$234,014
2019-05-01
BGNEWu XiaobinPres, GM ChinaS - Sale$124.53-5,9551,093,849-1%-$741,546
2019-05-01
BGNEOyler JohnCEOS - Sale$125.18-2,82464,546,0630%-$353,505
D
2019-04-08
BGNEHuang JaneCMO, HematologyS - Sale+OE$142.77-14,130271,621-5%-$2,017,315
2019-03-14
BGNEGlazer Donald W.DirS - Sale$136.10-14,9734,145,0290%-$2,037,825
DM
2019-03-07
BGNEHuang JaneCMO, HematologyS - Sale+OE$130.28-2,636271,621-1%-$343,426
M
2019-03-04
BGNEOyler JohnCEOS - Sale$151.73-25,49964,582,8750%-$3,868,938
DM
2018-12-17
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale+OE$133.68-20,000194,569-9%-$2,673,536
2018-12-10
BGNEOyler JohnCEOS - Sale$135.78-4,13864,914,2620%-$561,863
2018-12-03
BGNEWang XiaodongDirS - Sale$152.41-5,00012,932,9800%-$762,061
M
2018-11-26
BGNEOyler JohnCEOS - Sale$143.66-29,19564,918,4000%-$4,194,035
D
2018-11-26
BGNEHuang JaneCMO, HematologyS - Sale+OE$139.58-3,000271,621-1%-$418,750
2018-11-19
BGNEWang XiaodongDirS - Sale$124.30-5,00013,087,9790%-$621,490
DM
2018-11-08
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale+OE$120.20-40,000194,569-17%-$4,808,089
2018-09-04
BGNEHuang JaneCMO, HematologyS - Sale$174.59-2,911271,621-1%-$508,247
M
2018-08-29
BGNEGlazer Donald W.DirS - Sale$179.00-2,0004,188,4840%-$358,000
2018-08-23
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale$169.12-5,769194,569-3%-$975,666
2018-08-13
BGNEWang XiaodongDirS - Sale$158.77-3,44913,152,9790%-$547,591
2018-08-02
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$108.00+5,814,10017,224,519+51%+$627,922,800
2018-07-16
BGNEOyler JohnCEO, 10%S - Sale$164.12-2,55065,347,5910%-$418,497
DM
2018-03-16
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$160.27-40,0005,000-89%-$6,410,651
M
2018-02-28
BGNEOyler JohnCEO, 10%S - Sale$145.63-99,00064,617,5370%-$14,416,931
D
2018-02-28
BGNELi JiEVP, Gl. Head of Bus. Dev.S - Sale+OE$146.88-10,000475,000-2%-$1,468,760
2018-01-18
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$101.00+1,980,19884,830,765+2%+$199,999,998
2017-12-26
BGNEOyler JohnCEO, 10%S - Sale$96.47-20,13763,299,5500%-$1,942,515
D
2017-12-21
BGNEHuang JaneCMO, HematologyS - Sale+OE$98.00-1,000264,9000%-$98,000
D
2017-12-13
BGNEHuang JaneCMO, HematologyS - Sale+OE$94.25-1,500264,900-1%-$141,381
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top